✦ LIBER ✦

Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapy

✍ Scribed by S. Chiara; R. Lionetto; E. Campora; C. Oliva; L. Merlini; P. Bruzzi; R. Rosso; P.F. Conte

Book ID: 116166152
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 599 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(94)00487-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors for recurrence follow

Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy

✍ Stephen C. Rubin; William J. Hoskins; Patricia E. Saigo; Douglass Chapman; Thoma 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 534 KB

High-dose melphalan-based chemotherapy a

High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results

✍ Bertucci, F; Viens, P; Delpero, J R; Bardou, V J; Faucher, C; Houvenaeghel, G; M 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

Long-term survival data and prognostic f

Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: A hellenic co-operative oncology group study

✍ Fountzilas, George ;Kosmidis, Paris ;Avramidis, Vasilios ;Nikolaou, Angelos ;Kal 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 3 views

A group of 154 patients with locally advanced head and neck cancer, treated with platinum-based induction chemotherapy, were followed up for 5 years and several pretreatment characteristics were analyzed for possible correlation to a complete response (CR) to chemotherapy, time to progression (TTP)

A feasibility study of low-dose, prolong

A feasibility study of low-dose, prolonged oral topotecan in patients with advanced ovarian, fallopian tube, or primary peritoneal serous cancer who have attained a complete clinical response following platinum-based chemotherapy

✍ A.H. COMANDER; S.A. CANNISTRA 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB